Probing the mechanism of inhibition of amyloid-β(1–42)–induced neurotoxicity by the chaperonin GroEL
PNAS; https://doi.org/10.1073/pnas.1817477115.
Intradermal active full-length DNA Aβ42 immunization via electroporation leads to high anti-Aβ antibody levels in wild-type mice.
Alzheimer’s Research & Therapy; https://doi.org/10.1186/s13195-018-0441-4.
Inhibition of poly(ADP-ribose) polymerase-1 alters expression of mitochondria-related genes in PC12 cells: relevance to mitochondrial homeostasis in neurodegenerative disorders.
Science Direct; https://doi.org/10.1016/j.bbamcr.2017.11.003.
Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer’s disease
Springer; https://doi.org/10.1186/s40478-018-0626-x.
Effect of Varying Concentrations of Docosahexaenoic Acid on Amyloid Beta (1–42) Aggregation: An Atomic Force Microscopy Study.
www.mdpi.com; https://doi.org/10.3390/molecules23123089.
Amyloid-β Inhibits PDGFβ Receptor Activation and Prevents PDGF-BB-induced Neuroprotection.
Current Alzheimer Research; https://doi.org/10.2174/1567205015666180110110321.
Pharmacological Modulation of Three Modalities of CA1 Hippocampal Long-Term Potentiation in the Ts65Dn Mouse Model of Down Syndrome
www.hindawi.com; 10.1155/2018/9235796.
Effects of Prion Protein on Aβ42 and Pyroglutamate-Modified AβpΕ3-42 Oligomerization and Toxicity
Springer US; DOI: https://doi.org/10.1007/s12035-018-1202-x.
Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity.
https://jneuroinflammation.biomedcentral.com; .
Serum titers of autoantibodies against α-synuclein and tau in child- and adulthood.
www.sciencedirect.com; https://doi.org/10.1016/j.jneuroim.2017.12.003.